Across rheumatic diseases

Annual trends in pain management modalities in patients with newly diagnosed autoimmune rheumatic diseases in the USA from 2007 to 2021: an administrative claims-based study

Lancet RheumatolPublished Retrospective cohort study

Authors' conclusion

Since 2014, the use of non-opioid pain management modalities has increased or stabilised, whereas opioid and NSAID use has declined.

Study context

Population
Newly diagnosed AS, PsA, RA, Sjögren's syndrome, SSc or SLE in the Merative Marketscan Research Databases (US employment-sponsored insurance claims), 2007–2021107,475 (75.7%) women
Participants
141,962 participants
Exposure
Annual trends by calendar year, before vs after 2014
  • ASn = 10,927
  • PsAn = 21,438
  • RAn = 71,393
  • Sjögren's syndromen = 16,718
  • SLEn = 18,018
  • SScn = 3,468
Outcome
Annual incidence of patients treated with opioids, anticonvulsants, antidepressants, skeletal muscle relaxants, non-steroidal anti-inflammatory drugs (NSAIDs), topical analgesics and physical therapy
Follow-up
Year following diagnosis
Methodological detailsadministrative claims-based, logistic regression adjusted for age, sex and region
  • Administrative claims-based
  • Logistic regression adjusted for age, sex and region

Main finding

As reported in the abstract

Annual change in incidence of pain management modality use, by calendar year
Opioid use, annual change until 2014
aOR 1.04 (1.03-1.04) (95% CI)
Opioid use, annual change after 2014
aOR 0.85 (0.84-0.86) (95% CI)
Physical therapy use, annual change until 2014
aOR 1.05 (1.04-1.06) (95% CI)
Physical therapy use, annual change after 2014
aOR 0.99 (0.98-1.00) (95% CI)
Anticonvulsant use, annual change until 2014
aOR 1.07 (1.07-1.08) (95% CI)
Anticonvulsant use, annual change after 2014, not significant
aOR 1.00 (0.99-1.00) (95% CI)
NSAID use, annual change before 2014
aOR 1.02 (1.02-1.03) (95% CI)
NSAID use, annual change after 2014
aOR 0.95 (0.95-0.96) (95% CI)

Observational data: associations, not effects.

Further findings

Trends did not differ by sex except NSAID use before 2014
P for interaction = 0.02
Topical analgesic use after 2014 differed by sex
P for interaction = 0.0100

Original publication

Annual trends in pain management modalities in patients with newly diagnosed autoimmune rheumatic diseases in the USA from 2007 to 2021: an administrative claims-based study. Lancet Rheumatol. Published 27 June 2024. doi:10.1016/s2665-9913(24)00120-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.